The stimulant drug methylphenidate “normalizes” activation of several brain areas in young patients with attention-deficit/hyperactivity disorder (ADHD), according to a new review.
The stimulant drug methylphenidate “normalizes” activation of several brain areas in young patients with attention-deficit/hyperactivity disorder (ADHD), according to a new review.